AstraZeneca

11,300 AstraZeneca has 11,300 employees working in R&D $4bn AstraZeneca invests $4bn on R&D yearly (the average cost of launching a new drug) AstraZeneca is a British-Swedish pharmaceutical and biologics company operating in over 100 countries. The firm has a growing presence in emerging markets such as China, Brazil and Russia. Medicines manufactured by AstraZeneca […]

11,300

AstraZeneca has 11,300 employees working in R&D

$4bn

AstraZeneca invests $4bn on R&D yearly (the average cost of launching a new drug)

AstraZeneca is a British-Swedish pharmaceutical and biologics company operating in over 100 countries. The firm has a growing presence in emerging markets such as China, Brazil and Russia. Medicines manufactured by AstraZeneca are developed for use in areas of cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory and inflammation-related illnesses. Investing over $4bn annually on R&D, AstraZeneca demonstrates a continued commitment to producing prescription medicines of the highest quality.